BCR and chronic myelogenous leukemia, BCR-ABL1 positive: SNIPER(ABL)-39 effectively degraded the BCR-ABL protein, inhibited the phosphorylation of STAT5 and CRKL, and suppressed the growth of BCR-ABL-positive CML cells.